Table 3.
Interpretive antifungal susceptibility classification of Malassezia isolates according to the clinical origin into susceptible (S), susceptible dose-dependent (SDD), and resistant (R). Number of isolates (and percentage) by category.
| Malassezia Species Origin | Fluconazole | Ketoconazole | Itraconazole | Posaconazole | Amphotericin B | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | SDD | R | S | SDD | R | S | SDD | R | S | SDD | R | S | SDD | R | |
| Group 1 (40 isolates) |
0 (0) | 28 (70) | 12 (30) | 40 (100) | - | 0 (0) | 26 (65) | 6 (15) | 8 (20) | 39 (97.5) | 1 (0.02) | 0 (0) | 28 (70) | - | 12 (30) |
| Group 2 (18 isolates) |
5 (27.8) | 8 (44.4) | 5 (27.8) | 18 (100) | - | 0 (0) | 4 (22.2) | 6 (33.3) | 8 (44.5) * | 18 (100) | 0 (0) | 0 (0) | 6 (33.3) | - | 12 (66.6) * |
| Total | 5 (8.6) | 36 (62.1) | 17 (29.3) | 58 (100) | - | 0 (0) | 30 (51.7) | 12 (20.7) | 16 (27.6) | 57 (98.3) | 1 (1.7) | 0 (0) | 34 (58.6) | - | 24 (41.4) |
* The difference is statistically significant with p value < 0.05.